BACKGROUND & AIMS: Netrin-1 was recently proposed to play a crucial role during colorectal tumorigenesis by regulating apoptosis. Because netrin-1 receptors belong to the family of dependence receptors, a selective advantage for a tumor is either to lose netrin-1 receptors or to gain autocrine expression of netrin-1. We have investigated whether netrin-1 is up-regulated in colorectal cancer and have searched for a link between NF-kappaB activation and netrin-1 up-regulation. METHODS: The level of netrin-1, netrin-1 receptors, ie, DCC, UNC5H1, UNC5H2, UNC5H3, and the proinflammatory markers cyclooxygenase-2 and inhibitor of nuclear factor-kappaB (IkappaB) alpha were analyzed in a panel of 59 primary sporadic colorectal carcinomas. Netrin-1 expression was investigated in tumor cells and in mouse colonic crypts in response to NF-kappaB activation but also in a mouse model of inflammation-induced colorectal cancer. Binding of NF-kappaB to netrin-1 promoter and effect of NF-kappaB activation to the proapoptotic activity of UNC5H2 were also analyzed. RESULTS: We show that colorectal tumors with a gain of netrin-1 are tumors that display increased activation of the NF-kappaB pathway. Moreover, netrin-1 up-regulation, which is associated with tumor formation in mice, is observed in mouse colonic crypts in response to NF-kappaB activation but also in a mouse model of inflammation-induced colorectal cancer. We demonstrate that the netrin-1 gene is a direct transcriptional target of NF-kappaB. We show that NF-kappaB-induced netrin-1 expression inhibits proapoptotic activity of the netrin-1 receptors. CONCLUSIONS: We propose that NF-kappaB activation that occurs in response to inflammation confers a selective advantage for tumor development through NF-kappaB-mediated netrin-1 up-regulation.
BACKGROUND & AIMS:Netrin-1 was recently proposed to play a crucial role during colorectal tumorigenesis by regulating apoptosis. Because netrin-1 receptors belong to the family of dependence receptors, a selective advantage for a tumor is either to lose netrin-1 receptors or to gain autocrine expression of netrin-1. We have investigated whether netrin-1 is up-regulated in colorectal cancer and have searched for a link between NF-kappaB activation and netrin-1 up-regulation. METHODS: The level of netrin-1, netrin-1 receptors, ie, DCC, UNC5H1, UNC5H2, UNC5H3, and the proinflammatory markers cyclooxygenase-2 and inhibitor of nuclear factor-kappaB (IkappaB) alpha were analyzed in a panel of 59 primary sporadic colorectal carcinomas. Netrin-1 expression was investigated in tumor cells and in mouse colonic crypts in response to NF-kappaB activation but also in a mouse model of inflammation-induced colorectal cancer. Binding of NF-kappaB to netrin-1 promoter and effect of NF-kappaB activation to the proapoptotic activity of UNC5H2 were also analyzed. RESULTS: We show that colorectal tumors with a gain of netrin-1 are tumors that display increased activation of the NF-kappaB pathway. Moreover, netrin-1 up-regulation, which is associated with tumor formation in mice, is observed in mouse colonic crypts in response to NF-kappaB activation but also in a mouse model of inflammation-induced colorectal cancer. We demonstrate that the netrin-1 gene is a direct transcriptional target of NF-kappaB. We show that NF-kappaB-induced netrin-1 expression inhibits proapoptotic activity of the netrin-1 receptors. CONCLUSIONS: We propose that NF-kappaB activation that occurs in response to inflammation confers a selective advantage for tumor development through NF-kappaB-mediated netrin-1 up-regulation.
Authors: Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong Journal: Cell Mol Life Sci Date: 2011-11-09 Impact factor: 9.261
Authors: Jonathan Vial; Amélie Royet; Philippe Cassier; Antonin Tortereau; Sarah Dinvaut; Denis Maillet; Lise Gratadou-Hupon; Marion Creveaux; Alexa Sadier; Garance Tondeur; Sophie Léon; Lauriane Depaepe; Sophie Pantalacci; Arnaud de la Fouchardière; Olivier Micheau; Stéphane Dalle; Vincent Laudet; Patrick Mehlen; Marie Castets Journal: Cell Death Differ Date: 2018-05-31 Impact factor: 15.828
Authors: Janine M van Gils; Bhama Ramkhelawon; Luciana Fernandes; Merran C Stewart; Liang Guo; Tara Seibert; Gustavo B Menezes; Denise C Cara; Camille Chow; T Bernard Kinane; Edward A Fisher; Mercedes Balcells; Jacqueline Alvarez-Leite; Adam Lacy-Hulbert; Kathryn J Moore Journal: Arterioscler Thromb Vasc Biol Date: 2013-02-21 Impact factor: 8.311
Authors: M-L Plissonnier; T Lahlali; M Raab; M Michelet; C Romero-López; M Rivoire; K Strebhardt; D Durantel; M Levrero; P Mehlen; F Zoulim; R Parent Journal: Oncogene Date: 2017-08-07 Impact factor: 9.867